Abstract
Background: There is a lack of data regarding gender differences in atrial fibrillation presentation and clinical characteristics in Saudi Arabia. 
Objective: To assess gender differences in atrial fibrillation risk factors, presentation, and management strategy in Tabuk.
Methods: This retrospective cross-sectional study was conducted in King Fahad Specialist Hospital in Tabuk City, Saudi Arabia. The medical records of all patients with atrial fibrillation in the years 2016 and 2017 were approached using a structured questionnaire to collect demographic factors, atrial fibrillation risks including diabetes, hypertension, ischemic heart disease, valvular heart disease, respiratory diseases (Bronchial Asthma, chronic obstructive airways disease, and pulmonary fibrosis), cardiomyopathy, thyrotoxicosis, and congenital heart disease. The different types of atrial fibrillation, management strategy, and complications were also reported. IBM-SPSS version 20 was used for data analysis. The Chi-square test was applied to compare men and women.
Results: There were 93 patients with atrial fibrillation (59.2% males), hypertension, diabetes, ischemic heart disease, cardiomyopathy, thyrotoxicosis, congenital heart disease, and valvular heart disease was evident in 72%, 31.2%, 32.1%, 9.7%, 2.2%, 2.2%, and 10.7% respectively, while respiratory diseases, chronic atrial fibrillation, rate control strategy, and stroke were reported in 7.6%, 70.9%, 68.8%, and 16.1% of patients respectively.  Women were older and had more paroxysmal atrial fibrillation with significant statistical differences (p=0.010). No significant differences were evident regarding other characteristics.
Conclusion: No significant differences were found between males and females except age and paroxysmal atrial fibrillation, which were higher among women.
 
Keywords: Gender difference, Atrial fibrillation, Saudi Arabia

 

» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/7462
adidasChaussures Homme J.M. Weston

Current Issue

Volume 12, Issue 3, July-September 2020

 


 

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:


Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: